Article
Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase…
Journal of Immunology Research · 2018 · Martina Morelli, author Claudia Scarponi, author Laura Mercurio, author Francesco Facchiano, author Sabatino Pallotta, author Stefania Madonna, author Giampiero Girolomoni, author Cristina Albanesi, author Lihua Duan, Guest Editor
Key facts
| Title | Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis |
|---|---|
| First author | Martina Morelli, author Claudia Scarponi, author Laura Mercurio, author Francesco Facchiano, author Sabatino Pallotta, author Stefania Madonna, author Giampiero Girolomoni, author Cristina Albanesi, author Lihua Duan, Guest Editor |
| Journal | Journal of Immunology Research |
| Published | Apr 27, 2018 |
| DOI | 10.1155/2018/7897263 |
| Devices mentioned | BK140112, K010146, K010147, K010148, K041658, K043341, K062211, K062213, K063866, K072358, K073506, K080008 and 23 more |
| Product codes mentioned | GMQ, LIP, JIT, JIX, JJY, NHX, JJX, KTN, LJN, LFX, LFZ, LKQ and 31 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1